Understanding ADDYI Prescribing Information: A Guide for Patients
Many women suffer from Hypoactive Sexual Desire Disorder (HSDD), which is characterized by a persistent lack of sexual desire that causes them significant distress. While it can affect anyone, HSDD is more common in women who are postmenopausal or have undergone a hysterectomy. In 2015, the Food and Drug Administration (FDA) approved a drug called ADDYI to treat this condition. This article aims to give an overview of ADDYI prescribing information for patients who may be considering taking the medication.
What Is ADDYI?
ADDYI is the brand name for Flibanserin, a medication that was initially developed as an antidepressant. However, it was later found to be effective in treating HSDD in women. The active ingredient in ADDYI works on neurotransmitters in the brain, affecting the levels of dopamine, norepinephrine, and serotonin.
ADDYI is taken orally once a day at bedtime, and it may take several weeks of treatment before a woman sees the desired results. Women who take ADDYI are advised to avoid alcohol and to notify their doctor if they develop new or worsening symptoms of depression, suicidal thoughts, or mood changes.
How Does ADDYI Work?
ADDYI works by rebalancing the levels of neurotransmitters in the brain that affect sexual desire. It specifically targets the levels of dopamine, norepinephrine, and serotonin, all of which play a role in sexual motivation and drive. By increasing the levels of these neurotransmitters and decreasing the level of serotonin, ADDYI can help increase sexual desire in women with HSDD.
Who Can Take ADDYI?
ADDYI is only indicated for the treatment of HSDD in premenopausal women. It is not advised for use in men or postmenopausal women. Women who are pregnant or breastfeeding should not take ADDYI.
Furthermore, not all patients with HSDD are suitable for ADDYI. Doctors will need to evaluate a patient’s medical history, current medications, and other factors before prescribing ADDYI. Women who have liver or kidney disease, low blood pressure, or who take medications that interact with ADDYI should not take the drug.
Side Effects of ADDYI
Like any medication, ADDYI can cause side effects. The most common side effects of ADDYI are dizziness, somnolence, nausea, fatigue, insomnia, and dry mouth. It can also cause low blood pressure, fainting, and an increased risk of falls. In rare cases, it can cause more severe side effects such as liver injury, severe allergic reactions, and syncope.
Conclusion
ADDYI is a medication that is specifically designed to treat HSDD in premenopausal women. It works by rebalancing the levels of neurotransmitters in the brain that affect sexual desire. However, before a woman is prescribed ADDYI, her doctor will have to evaluate her medical history, current medications, and other factors to ensure that she is a suitable candidate for the medication. Women who take ADDYI must also be aware of the potential side effects and follow their doctor’s instructions carefully. While it may not be for everyone, ADDYI can provide a treatment option for women who are struggling with HSDD and who have not found relief from other therapies.
